OneVentures • 21 August 2017

Prota Therapeutics releases data from four year immunotherapy study with outstanding results

OneVentures

Read more from the following outlets:

BBC News

The Age

CBS News

ABC News

SBS News

Australian Doctor

Nine News

You may also like

23 May 2018

Healthcare

Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003)


18 April 2018

OneVentures

Prota Therapeutics partners with world leading bioscience company, Chr. Hansen


27 May 2017

OneVentures

OneVentures makes first investment for the Biomedical Translation Fund


07 April 2017

OneVentures

Australia’s ProTA accelerates the development of immunotherapy to treat peanut allergy


View All